Nephrology Flashcards
Acidemia
pH <7.35
- increase [H] ion in blood
Acidosis
Increasing [H] ion in arterial blood plasma (acidemia), pH <7.35
Alkalemia
pH >7.45
- reduced [H] in blood
Alkalosis
Reducing [H] ion in arterial blood plasma (aklalemia); pH >7.45
Henderson equation for H+
H (mEq/L) = 24 x PCO2/HCO3
Respiratory acidosis
pH <7.35
increased pCO2
increased HCO3
Metabolic acidosis
pH <7.35
decreased pCO2
decreased HCO3
Respiratory alkalosis
pH >7.45
decreased pCO2
decreased HCO3
Metabolic alkalosis
pH >7.45
increased pCO2
increased HCO3
Compensation appropriate?
Metabolic acidosis: HCO3 decreased by 1mmol/L, PCO2 decreased by 1.25 mmHg
Metabolic alkalosis: HCO3 increased by 1mmol/L, PCO2 increased by 0.2-0.9 mmHg
Acute respiratory acidosis: PCO2 increased by 10mmHg, HCO3 increased by 1mmol/L
Acute respiratory alkalosis: PCO2 decreased by 10mmHG, HCO3 reduced by 2.5mmol/L
Chronic respiratory acidosis: PCO2 increased by 10mmHg, HCO3 increased by 5mmol/L
Chronic respiratory alkalosis: PCO2 reduced by 10mmHG, HCO3 reduced by 5mmol/L
Anion Gap
AG = Na - Cl - HCO3
normal 8-14 mEq/L
increased in AG metabolic acidosis
**always calculate to make sure no mixed disorder
AG decreases by 4 for every drop of albumin by 10g/L
change gap
change HCO3 = 24 - HCO3
change AG = calculated - normal (12)
change HCO3 > change AG = simultaneous non-AG metabolic acidosis
change AG > change HCO3 = simultaneous metabolic alkalosis
change AG = change HCO3 = only AG metabolic acidosis
Ddx respiratory acidosis & tx
CNS
- brainstem injury (stroke, tumor)
- central sleep apnea
- obesity hypoventilation syndrome
Resp
- upper airway obstruction: laryngospasm, epiglottitis
- lower airway obstruction: COPD, asthma, sleep apnea
- dead space ventilation: infection, pleural effusion
Muscular
- myasthenia gravis, Guillain-Barre, myopathy, ALS, hypokalemia
Drugs
- opioids
Tx- intubation, mechanical ventilation, treat underlying disease, naloxone, etc.
Ddx AG metabolic acidosis & tx
MUDPILES Methanol Uremia DKA, alcoholic KA, starvation KA Paraldehyde, phenformin, metformin Iron, isoniazide Lactic acidosis Ethylene glycol Salicylates Cyanide Arsenic Toluene
Tx - correct underlying disorder; NaHCO3 if pH <7.2; HCO3 deficit (mmol) = (desired bicarb - measured bicarb) xweight (kg) x 0.6 replace 1/2 total deficit over 8-12h
Ddx Non-AG metabolic acidosis & tx
USED CAR Ureteroenteric fistula Saline (IV NS) Early renal failure Diarrhea Carbonic anhydrase inhibitors (acetazolamide) Amphotericin RTA I, II, IV
Tx - correct underlying disorder; NaHCO3 if pH <7.2; HCO3 deficit (mmol) = (desired bicarb - measured bicarb) xweight (kg) x 0.6 replace 1/2 total deficit over 8-12h
Ddx respiratory alkalosis & tx
Cardiopulmonary - hypoxia - pneumonia - early restrictive lung disease - mild CHF - PE - mechanical ventilation Non-cardiopulmonary - fever, sepsis, anxiety, pregnancy, hyperthyroidism, liver failure Drugs - salicylate, progesterone
Tx- underlying disorders, hyperventilation - rebreather into paperbag
Ddx metabolic alkalosis & tx
Saline responders - GI loss (vomiting, NG suction) - renal loss (diuretics) - skin loss (burns, sweat) - reduced fluid intake Saline non-responders - mineralocortisolism (Conn's syndrome, Cushing syndrome) - renin production (tumor) - severe hypoK - Gitelmann syndrome - Barter syndrome - HCO3 load (sodium bicarb infusion, citrate with transfusions, acetate with TPN)
Tx - saline responses = volume repletion
- saline non responders = tx underlying issue
Urinary Na vs. Cl re: volume status
- metabolic acidosis = Na better surrogate for volume status (Cl excreted in excess with NH4+)
- metabolic alkalosis = Cl better surrogate for volume status (Na excreted in excess with HCO3)
Hypomagnesemia
- [Mg2+] <1.5 mEq/L pr 0.75mmol/L
(normal 1.5-2 mEq/L or 0.75-1 mmol/L or 1.7-2.4 mg/dL)
often associated with hypoK and hypoCa (chronic hypoMg = reduced PTH secretion and bone response to PTH)
1% total Mg in ECF
70% Mg filterable -> calculating FEMg = x0.7
95% filtered Mg reabsorbed
Altered Mg excretion
- hyperCa, hyperMg = reduced Mg reabsorption
- reduced GFR = reduced Mg reabsorption
- phosphate depletion = increase Mg excretion
- chronic metabolic acidosis = increased Mg excretion
- chronic metabolic alkalosis = decreased Mg excretion
Redistribution of Mg
- hungry bones
- referring syndrome (redistribution to bones)
- DM
Hyperkalemia
Serum K >5 mEq/L
2% K extracellular
98% muscle, liver, RBCs
excretion mainly renal (minimal sweat)
K Adaptation
- renal response to prolonged increase in K load
- significant increase in efficiency of renal K excretion
- mediated by enhanced activity of Na/K ATPase of renal principal cells
- gradual return of K and aldosterone levels to normal
- reabsorption of K in PCT and loop of Henle remains at constant rate
PsuedohyperK
- hemolysis blood
- severe leukocytosis
- severe thrombocytosis
Ddx hyperK
- shifting
- increased efflux: damage to intracellular K storage, acidosis, succinylcholine, diazoxide, minoxidil, isoflurane, hyperkalemia period paralysis
- decreased influx: lack of insulin, beta-blockers, dioxin OD
- decreased excretion - reduced GFR, decreased aldosterone, volume depletion, decreased from stool/sweat
HyperK on ECG
- peaked T waves (tented narrow based, >10mm in precordial, >5mm in limb leads or relatively tall vs. baseline)
- shortened QT
- prolonged PR interval, then QRS
- P wave flattening then disappears
- sine wave pattern (K>8)
- ventricular standstill (flat line)
- arrhythmias (bradycardia, v-tach, v-fib)
Tx hyperK
ECG changes (K>7) - calcium gluconate or calcium chloride (stabilize membrane) No ECG changes (K = 6.5-7) - insulin with glucose, B-agonist, sodium bicarb if acidotic (shifting) No ECG changes (K <6.5) - diuretics, caution-exchange resins, dialysis (K removal)
HypoK
Serum K <3.5 mEq/L
- often multifactorial, chronic and symptoms develop late
approx. decrease by 0.27 mEq/L = 100mEq deficit
Diuretics and hypoK
Loop and thiazide diuretics = Cl depletion and hypovolemia with metabolic alkalosis
K depletion via
- increased flow and delivery of NaCl to CCD
- alkalemia (redistribution)
- hypovolemia with activation of RAAS
Severe/life threatening HypoK
K <2.5 - 3 mEq/L
sx - weakness starts in lower extremities and progresses to upper extremities, respiratory muscle paralysis, rhabdomyolysis; ileus; arrhythmias, ECG changes
TX
-replace immediately but caution re: rebound hyperK (max K IV rate 20 mEq/h, oral 60mEq)
40-60 mEq = increase K by 1-1.5 mEq/L
K shifting re: hypoK
- increased Na/K ATPase activity –> insulin, b-adrenergic
- increased pH (H out, K in)
- hypoK periodic paralysis (mutation Ca channel)
- increased uptake from plasma in acute increase hematopoietic cell production
- hypothermia
- barium, caesium, chloroquine intoxication (block K channels)
- resperidone or quetiapine OD
Proteinuria
urinary total protein excretion >150 mg/d with >30mg/d albumin
- > risk marker for cardiovascular disease
- only albuminuria detected by urine dipstick (not reliable for microalbuminuria) -> check urine micro albumin to creatinine ratio (ACR) if risk of renal disease
- urine protein to creatinine ratio (PCR) detects all protein in urine, not sensitive at low values
severity
>2g/d - likely glomerular disease
0.15 - 2g/d - likely tubular proteinuria, overflow proteinuria, or mild glomerular disease
Microalbuminuria
30-300 mg/d albumin
Nephrotic proteinuria
> 3.5g/d total protein
Ddx proteinuria
- benign
- transient intermittent (fever, dehydration, exercise)
- orthostatic (>50mg/8h while upright)
Persistent - Glomerular (glomerular permeability to protein)- nephritic syndrome, glomerularnephritis, systemic disorders; nephrotic syndrome, diabetic nephropathy, FSGS
- Tubular (reduced reabsorption of filtered proteins)- tubule-interstitial disease, drugs, chronic pyelonephritis, Fanconi, sickle cell disease, etc.
- Overflow (filtered load > tubular reabsorptive capacity)- multiple myeloma, MGUS, amyloid, hemoglobinuria, myoglobinuria
Normally excreted proteins
40% Tamm-Horsfall mucoproteins
40% albumin
20% Igs
Tx primary glomerular disease
corticosteroids, diuretics, cytotoxic agents, anti-HTN, plasmapheresis as indicated
Tx HTN related proteinuria
BP target <125/75
ACEI, ARBs preferred (proteinuria-reducing effect independent of anti-HTN)
Hyaline casts
No renal pathology - dehydration, diurectics
RBC casts
glomerular disease
Dysmorphic RBCs
upper urinary tract pathology
Intact RBCs
lower urinary tract pathology
WBCs, WBC casts, bacteria
UTI/inflammation
Fatty cast, oval fat bodies, free fat
Nephrotic proteinuria
Waxy, granular or cellular casts
Advanced chronic renal disease
Eosinophiluria
Acute interstitial nephritis
Glomerular filtration barrier
- degree of proteinuria depends on integrity of barrier (charge and size) and intraglomerular (filtration) pressure
Slit diaphragm - pores that limit passage
Visceral glomerular epithelial cell (podocyte) foot processes
GBM - limits size and negatively charged particles
Cappilary endothelial cells - limit negative charged particles; fenestrations limit size